Jennifer Barker, MD
Professor, Pediatrics-Endocrinology

Publications

• Dyess NF, Weikel BW, Barker JM, Garrington TP, Parker TA. Parental leave during pediatric fellowship training: A national survey. PLoS One. 2022;17(12):e0279447. PubMed PMID: 36548290
• Singh I, Noel G, Barker JM, Chatfield KC, Furniss A, Khanna AD, Nokoff NJ, Patel S, Pyle L, Nahata L, Cole FS, Ikomi C, Bamba V, Fechner PY, Davis SM. Hepatic abnormalities in youth with Turner syndrome. Liver Int. 2022 Oct;42(10):2237-2246. PubMed PMID: 35785515
• Guzewicz L, Howell S, Crerand CE, Umbaugh H, Nokoff NJ, Barker J, Davis SM. Clinical phenotype and management of individuals with mosaic monosomy X with Y chromosome material stratified by genital phenotype. Am J Med Genet A. 2021 May;185(5):1437-1447. PubMed PMID: 33616298
• Barker JM. A Window into Understanding the Lasting Impact of the Nutritional Milieu in Adolescents: Anorexia Nervosa as a Model. J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1905-e1906. PubMed PMID: 33492368
• Barker JM, Bajaj L. Hypo and Hyper: Common Pediatric Endocrine and Metabolic Emergencies. Adv Pediatr. 2015 Aug;62(1):257-82. PubMed PMID: 26205117
• Barker JM, Bajaj L. Hypo and Hyper: Common Pediatric Endocrine and Metabolic Emergencies. Adv Pediatr. 2015 Aug;62(1):257-82. PubMed PMID: 26205117
• Chan CL, McFann K, Taylor L, Wright D, Zeitler PS, Barker JM. Congenital adrenal hyperplasia and the second newborn screen. J Pediatr. 2013 Jul;163(1):109-13.e1. PubMed PMID: 23414665
• Barker JM. Compounding risk for hypoglycemia: type 1 diabetes and Addison's disease. Diabetes Technol Ther. 2012 May;14(5):383-5. PubMed PMID: 22506859
• Baker PR, Nanduri P, Gottlieb PA, Yu L, Klingensmith GJ, Eisenbarth GS, Barker JM. Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies. Clin Endocrinol (Oxf). 2012 May;76(5):617-24. PubMed PMID: 22066755
• Popler J, Alimohammadi M, Kämpe O, Dalin F, Dishop MK, Barker JM, Moriarty-Kelsey M, Soep JB, Deterding RR. Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol. 2012 Jan;47(1):84-7. PubMed PMID: 21901851